Skip to content
  • What we do >
    • RNA therapeutics
    • Target identification
  • Our technology >
    • The QLattice®
    • Why Abzu
    • Publications + preprints
  • About Abzu >
    • About Abzu
    • Meet the Abzoids
    • Careers
    • Investors
    • Scientific advisory board
  • News >
    • Press releases
    • Media
    • Awards
Menu
  • What we do >
    • RNA therapeutics
    • Target identification
  • Our technology >
    • The QLattice®
    • Why Abzu
    • Publications + preprints
  • About Abzu >
    • About Abzu
    • Meet the Abzoids
    • Careers
    • Investors
    • Scientific advisory board
  • News >
    • Press releases
    • Media
    • Awards
CONTACT US >

Category: case study

Improving cancer biomarker discovery and design

Improving cancer biomarker discovery and design

Our simple models accurately predicted and explained treatment responses for Checkmate Pharmaceuticals

Reducing R&D risk for top-10 pharmaceutical company

Reducing R&D risk with explainable AI

Our explainable models yielded a 44 percentage point improvement in catching toxic drugs in the drug development pipeline

  • Documentation
  • Quick start
  • Using Feyn
  • Community QLattice
  • Tutorials
  • API reference
  • FAQ
  • Community support on Discord
  • Privacy policy
  • End user license agreement
Twitter Instagram Linkedin-in